US Global Investors Funds’s Quest Diagnostics DGX Stock Holding History

US Global Investors Funds’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$193K	Buy	+3,600	New	+$214K	0.03%	256

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

US Global Investors Funds's DGX Position: Q4 2013 in Review

US Global Investors Funds opened a new position in Quest Diagnostics (DGX) in Q4 2013: 3,600 shares worth $193K. The stake represents 0.03% of the portfolio and ranks #256 among its holdings.

455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

US Global Investors Funds held 3,600 shares of Quest Diagnostics worth $193K as of Q4 2013.
Quest Diagnostics was a new US Global Investors Funds position in Q4 2013.
Quest Diagnostics made up 0.03% of US Global Investors Funds's portfolio in Q4 2013, its #256 holding.
455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.